Premier Perspectives The blog for insider insights in clinical development Consulting Design Considerations in Nonclinical Development of Cell and Gene Therapies By Premier Research April 23, 2024 Featured Posts Medical and Regulatory Affairs 4 Scenarios When High Risk Devices May Be Exempt from Mandatory Clinical Investigations Under EU MDR By Premier Research April 17, 2024 Clinical ResearchPhase 1 - Phase 4 Mastering Dose Escalation Studies Part 1: Optimizing Efficiency in Phase I Trial Execution Using Adaptive Design By Premier Research April 8, 2024 Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 5 Stages of Medical Device Development By Premier Research March 1, 2024 Why Rare Disease Day Matters to Us By Premier Research February 29, 2024 A World Cancer Day Message from the People of Premier By Premier Research February 2, 2024 Clinical ResearchPhase 1 - Phase 4 The Multi-Faceted World of Clinical Trial Matching in Precision Oncology Studies By Premier Research September 1, 2023 Medical and Regulatory Affairs Rare Oncology and the FDA: Taking the Guesswork Out of Expedited Pathways By Premier Research June 7, 2023 Clinical ResearchPhase 1 - Phase 4 Beyond Boundaries: Revolutionary CAR-T Therapies Pave Way to Conquer Solid Tumors By Premier Research April 24, 2023 1 2 3 … 17 Next × ALSO OF INTERESTGene Therapy 101: From the 1960s to Today7 Questions About Clinical Evaluations for MDRNostalgia or Shell Shock? Assessing PTSD Is a...